Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 02, 2026 32.72M
October 01, 2026 32.72M
September 30, 2026 30.53M
September 29, 2026 30.97M
September 28, 2026 31.19M
September 25, 2026 30.97M
September 24, 2026 31.84M
September 23, 2026 31.62M
September 22, 2026 31.62M
September 21, 2026 32.50M
September 18, 2026 32.06M
September 17, 2026 31.51M
September 16, 2026 29.43M
September 15, 2026 34.25M
September 14, 2026 34.47M
September 11, 2026 35.57M
September 10, 2026 36.88M
September 09, 2026 38.41M
September 08, 2026 42.14M
September 04, 2026 43.45M
September 03, 2026 45.42M
September 02, 2026 46.52M
September 01, 2026 46.74M
August 31, 2026 49.80M
August 28, 2026 52.87M
Date Value
August 27, 2026 56.37M
August 26, 2026 55.93M
August 25, 2026 56.59M
August 24, 2026 55.93M
August 21, 2026 57.25M
August 20, 2026 58.02M
August 19, 2026 59.22M
August 18, 2026 58.78M
August 17, 2026 56.81M
August 14, 2026 58.34M
August 13, 2026 59.66M
August 12, 2026 57.69M
August 11, 2026 57.03M
August 10, 2026 58.56M
August 07, 2026 60.53M
August 06, 2026 59.44M
August 05, 2026 60.53M
August 04, 2026 59.88M
August 03, 2026 53.31M
July 31, 2026 51.99M
July 30, 2026 54.40M
July 29, 2026 53.96M
July 28, 2026 55.28M
July 27, 2026 56.37M
July 24, 2026 56.37M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 620.93M
Amgen, Inc. 261.20B
BioCryst Pharmaceuticals, Inc. 2.569B
Imunon, Inc. 6.953M
Curis, Inc. -3.007M

Enterprise Value Related Metrics